GlassScriptPhysician profile
Abdul A Saboory
NPI 1790465375
$1,807.62
in general payments reported to CMS, 2019-2025
21 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,072 · 2024: $210 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $309.36 | 2023-2025 | Lifevest |
| Amgen INC. | $274.10 | 2023-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $225.59 | 2023-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $130.61 | 2023-2024 | Verquvo |
| Penumbra, INC. | $115.35 | 2025 | Indigo System |
| Novartis Pharmaceuticals Corporation | $115.18 | 2023-2024 | |
| Pfizer INC. | $104.93 | 2023-2025 | |
| Zoll Circulation INC | $103.00 | 2023 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Astrazeneca Pharmaceuticals LP | $79.13 | 2023-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.52 | 2023 | Jardiance |
| Boston Scientific Corporation | $52.43 | 2023 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $41.64 | 2023 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $30.87 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $29.25 | 2023 | Injectafer |
| Cvrx, INC. | $25.25 | 2025 | Barostim Neo System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $23.41 | 2023 | Inpefa |
| Zoll Respicardia, INC. | $21.92 | 2023 | Remede System |
| Bayer Healthcare Pharmaceuticals INC. | $19.54 | 2025 | |
| Alnylam Pharmaceuticals INC. | $18.04 | 2023 | Amvuttra |
| Corcept Therapeutics | $17.06 | 2023 | Korlym |
| Angiodynamics, INC. | $14.44 | 2024 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Saboory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.